FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944137900> ?p ?o ?g. }

• W2944137900 endingPage "20315" @default.
• W2944137900 startingPage "20304" @default.
• W2944137900 abstract "Rheumatoid arthritis (RA) is a chronic, systemic, progressive autoimmune disease. The vascular permeability of inflamed joints in RA makes it a natural candidate for passive targeting, similar to the enhanced permeability and retention (EPR) effect in solid tumors. Thus, various therapeutic drugs have been encapsulated in nanocarriers to achieve longer in vivo circulation times and improve RA targeting. Although liposomes are the most widely used nanocarriers for RA treatment, the effects of physical and chemical characteristics of liposomes, such as particle sizes, surface charge, polyethylene glycol (PEG) chain length, and PEG concentration, on their passive RA targeting effect have not been fully elucidated. Here, we systematically investigated the effects of physical and chemical properties of liposomes on circulation time and conducted preliminary studies on their passive targeting mechanisms. A series of liposomes with different particle sizes (70, 100, 200, and 350 nm), surface charges (positive, negative, slight positive, and slight negative), PEG chain lengths (1, 2, and 5 kDa), and concentrations (5, 10, and 20% w/w of total lipid) were prepared by lipid film dispersion and extrusion. The pharmacokinetics of liposomes with different formulas were evaluated with a fluorescence microplate reader. A collagen-induced arthritis (CIA) mouse model was utilized to mimic RA pathological conditions and to evaluate the targeting and efficacy of liposomes with different properties using a near-infrared fluorescence imaging system. Uptake of fluorescent liposomes by various synovial cells was measured by flow cytometry. The results indicated that liposomes with 100 nm diameter, a slight negative charge, and 10% incorporation of 5 kDa PEG had better in vivo circulation time and inflamed joint targeting than did other liposomes. Dexamethasone (Dex) was encapsulated into optimized liposomes as an active ingredient for RA treatment. Pharmacodynamic studies demonstrated that Dex liposomes could significantly improve the antiarthritic efficacy of Dex in a CIA mouse model of RA. This study also found that the retention mechanism of RA was mainly increased because of the uptake of liposomes by fibroblasts and macrophages in inflamed joints. This study provides a persuasive explanation for passive RA targeting by liposomes and advances our ability to treat RA with nanomedicine." @default.
• W2944137900 created "2019-05-16" @default.
• W2944137900 creator A5000865193 @default.
• W2944137900 creator A5032975354 @default.
• W2944137900 creator A5039204230 @default.
• W2944137900 creator A5040730790 @default.
• W2944137900 creator A5049148912 @default.
• W2944137900 creator A5067764982 @default.
• W2944137900 creator A5069525077 @default.
• W2944137900 creator A5077610122 @default.
• W2944137900 creator A5079169653 @default.
• W2944137900 creator A5085823213 @default.
• W2944137900 date "2019-05-06" @default.
• W2944137900 modified "2023-10-15" @default.
• W2944137900 title "Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy" @default.
• W2944137900 cites W1451856554 @default.
• W2944137900 cites W1512179335 @default.
• W2944137900 cites W1605132184 @default.
• W2944137900 cites W1964067749 @default.
• W2944137900 cites W1964789241 @default.
• W2944137900 cites W1965097716 @default.
• W2944137900 cites W1977467418 @default.
• W2944137900 cites W1978002868 @default.
• W2944137900 cites W1981904613 @default.
• W2944137900 cites W1985241728 @default.
• W2944137900 cites W1988313934 @default.
• W2944137900 cites W1995945454 @default.
• W2944137900 cites W2002516695 @default.
• W2944137900 cites W2006958200 @default.
• W2944137900 cites W2012713305 @default.
• W2944137900 cites W2015497529 @default.
• W2944137900 cites W2016077190 @default.
• W2944137900 cites W2021367421 @default.
• W2944137900 cites W2029715328 @default.
• W2944137900 cites W2038040314 @default.
• W2944137900 cites W2038717222 @default.
• W2944137900 cites W2040103773 @default.
• W2944137900 cites W2043023393 @default.
• W2944137900 cites W2044717523 @default.
• W2944137900 cites W204512410 @default.
• W2944137900 cites W2046926512 @default.
• W2944137900 cites W2047816812 @default.
• W2944137900 cites W2054745605 @default.
• W2944137900 cites W2054847598 @default.
• W2944137900 cites W2054889106 @default.
• W2944137900 cites W2063022713 @default.
• W2944137900 cites W2063838991 @default.
• W2944137900 cites W2066444468 @default.
• W2944137900 cites W2072770602 @default.
• W2944137900 cites W2073611489 @default.
• W2944137900 cites W2074438676 @default.
• W2944137900 cites W2078057254 @default.
• W2944137900 cites W2079184456 @default.
• W2944137900 cites W2090515998 @default.
• W2944137900 cites W2093588753 @default.
• W2944137900 cites W2093627967 @default.
• W2944137900 cites W2095187713 @default.
• W2944137900 cites W2097027235 @default.
• W2944137900 cites W2098561601 @default.
• W2944137900 cites W2101312385 @default.
• W2944137900 cites W2111357501 @default.
• W2944137900 cites W2114433766 @default.
• W2944137900 cites W2114932791 @default.
• W2944137900 cites W2115543562 @default.
• W2944137900 cites W2117216132 @default.
• W2944137900 cites W2119310864 @default.
• W2944137900 cites W2124730525 @default.
• W2944137900 cites W2131538212 @default.
• W2944137900 cites W2133039447 @default.
• W2944137900 cites W2134626448 @default.
• W2944137900 cites W2146607274 @default.
• W2944137900 cites W2149026148 @default.
• W2944137900 cites W2150146274 @default.
• W2944137900 cites W2151138870 @default.
• W2944137900 cites W2190141802 @default.
• W2944137900 cites W2322047794 @default.
• W2944137900 cites W2562497953 @default.
• W2944137900 cites W2775038541 @default.
• W2944137900 cites W2793213766 @default.
• W2944137900 doi "https://doi.org/10.1021/acsami.8b22693" @default.
• W2944137900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31056910" @default.
• W2944137900 hasPublicationYear "2019" @default.
• W2944137900 type Work @default.
• W2944137900 sameAs 2944137900 @default.
• W2944137900 citedByCount "108" @default.
• W2944137900 countsByYear W29441379002019 @default.
• W2944137900 countsByYear W29441379002020 @default.
• W2944137900 countsByYear W29441379002021 @default.
• W2944137900 countsByYear W29441379002022 @default.
• W2944137900 countsByYear W29441379002023 @default.
• W2944137900 crossrefType "journal-article" @default.
• W2944137900 hasAuthorship W2944137900A5000865193 @default.
• W2944137900 hasAuthorship W2944137900A5032975354 @default.
• W2944137900 hasAuthorship W2944137900A5039204230 @default.
• W2944137900 hasAuthorship W2944137900A5040730790 @default.
• W2944137900 hasAuthorship W2944137900A5049148912 @default.
• W2944137900 hasAuthorship W2944137900A5067764982 @default.
• W2944137900 hasAuthorship W2944137900A5069525077 @default.

• next